Annual Accounts Payable
$4.08 M
+$1.61 M+65.58%
December 31, 2023
Summary
- As of February 8, 2025, VTVT annual accounts payable is $4.08 million, with the most recent change of +$1.61 million (+65.58%) on December 31, 2023.
- During the last 3 years, VTVT annual accounts payable has risen by +$2.15 million (+111.69%).
- VTVT annual accounts payable is now -15.72% below its all-time high of $4.83 million, reached on December 31, 2013.
Performance
VTVT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
N/A
September 30, 2024
Summary
- VTVT quarterly accounts payable is not available.
Performance
VTVT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VTVT Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +65.6% | - |
3 y3 years | +111.7% | - |
5 y5 years | +40.6% | - |
VTVT Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +117.2% | ||
5 y | 5-year | at high | +117.2% | ||
alltime | all time | -15.7% | +117.2% |
VTv Therapeutics Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $4.08 M(+65.6%) | $4.08 M(+65.6%) |
Dec 2022 | $2.46 M(+31.2%) | $2.46 M(+31.2%) |
Dec 2021 | $1.88 M(-2.5%) | $1.88 M(-2.5%) |
Dec 2020 | $1.93 M(-13.8%) | $1.93 M(-13.8%) |
Dec 2019 | $2.23 M(-23.0%) | $2.23 M(-67.6%) |
Sep 2019 | - | $6.90 M(-17.2%) |
Jun 2019 | - | $8.33 M(+33.3%) |
Mar 2019 | - | $6.24 M(+115.4%) |
Dec 2018 | $2.90 M(+27.8%) | $2.90 M(-67.7%) |
Sep 2018 | - | $8.96 M(-31.8%) |
Jun 2018 | - | $13.14 M(+16.4%) |
Mar 2018 | - | $11.30 M(+397.8%) |
Dec 2017 | $2.27 M | $2.27 M(-77.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2017 | - | $10.12 M(-5.7%) |
Jun 2017 | - | $10.73 M(-3.3%) |
Mar 2017 | - | $11.11 M(+262.9%) |
Dec 2016 | $3.06 M(-26.1%) | $3.06 M(-71.0%) |
Sep 2016 | - | $10.56 M(+7.8%) |
Jun 2016 | - | $9.80 M(+14.3%) |
Mar 2016 | - | $8.58 M(+107.1%) |
Dec 2015 | $4.14 M(+55.7%) | $4.14 M(-28.0%) |
Sep 2015 | - | $5.76 M(-50.1%) |
Jun 2015 | - | $11.52 M(+31.4%) |
Mar 2015 | - | $8.77 M(+229.7%) |
Dec 2014 | $2.66 M(-45.0%) | $2.66 M |
Dec 2013 | $4.83 M | - |
FAQ
- What is vTv Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for vTv Therapeutics?
- What is vTv Therapeutics annual accounts payable year-on-year change?
- What is the all time high quarterly accounts payable for vTv Therapeutics?
What is vTv Therapeutics annual accounts payable?
The current annual accounts payable of VTVT is $4.08 M
What is the all time high annual accounts payable for vTv Therapeutics?
vTv Therapeutics all-time high annual accounts payable is $4.83 M
What is vTv Therapeutics annual accounts payable year-on-year change?
Over the past year, VTVT annual accounts payable has changed by +$1.61 M (+65.58%)
What is the all time high quarterly accounts payable for vTv Therapeutics?
vTv Therapeutics all-time high quarterly accounts payable is $13.14 M